nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—umbilical vein—urinary bladder cancer	0.0365	0.163	CbGeAlD
Trandolapril—ACE—urine—urinary bladder cancer	0.0295	0.131	CbGeAlD
Trandolapril—CES1—prostate gland—urinary bladder cancer	0.0159	0.0709	CbGeAlD
Trandolapril—SLC15A1—epithelium—urinary bladder cancer	0.0108	0.0484	CbGeAlD
Trandolapril—ACE—prostate gland—urinary bladder cancer	0.0106	0.0472	CbGeAlD
Trandolapril—SLC15A1—renal system—urinary bladder cancer	0.0101	0.0449	CbGeAlD
Trandolapril—SLC15A2—prostate gland—urinary bladder cancer	0.00922	0.0412	CbGeAlD
Trandolapril—ACE—seminal vesicle—urinary bladder cancer	0.00895	0.0399	CbGeAlD
Trandolapril—Mitiglinide—UGT2B7—urinary bladder cancer	0.00879	0.339	CrCbGaD
Trandolapril—CES1—female reproductive system—urinary bladder cancer	0.00868	0.0387	CbGeAlD
Trandolapril—Aspartame—TRPV1—urinary bladder cancer	0.00857	0.33	CrCbGaD
Trandolapril—SLC15A2—seminal vesicle—urinary bladder cancer	0.0078	0.0348	CbGeAlD
Trandolapril—ACE—epithelium—urinary bladder cancer	0.00777	0.0347	CbGeAlD
Trandolapril—ACE—smooth muscle tissue—urinary bladder cancer	0.00749	0.0334	CbGeAlD
Trandolapril—SLC15A1—vagina—urinary bladder cancer	0.00728	0.0325	CbGeAlD
Trandolapril—ACE—renal system—urinary bladder cancer	0.00721	0.0322	CbGeAlD
Trandolapril—ACE—urethra—urinary bladder cancer	0.00708	0.0316	CbGeAlD
Trandolapril—SLC15A2—renal system—urinary bladder cancer	0.00629	0.0281	CbGeAlD
Trandolapril—SLC15A2—urethra—urinary bladder cancer	0.00618	0.0276	CbGeAlD
Trandolapril—ACE—female reproductive system—urinary bladder cancer	0.00577	0.0258	CbGeAlD
Trandolapril—CES1—lymph node—urinary bladder cancer	0.00508	0.0227	CbGeAlD
Trandolapril—SLC15A2—female reproductive system—urinary bladder cancer	0.00503	0.0225	CbGeAlD
Trandolapril—SLC15A2—vagina—urinary bladder cancer	0.00455	0.0203	CbGeAlD
Trandolapril—Mitiglinide—PPARG—urinary bladder cancer	0.00343	0.132	CrCbGaD
Trandolapril—Benazepril—MTHFR—urinary bladder cancer	0.00342	0.132	CrCbGaD
Trandolapril—ACE—lymph node—urinary bladder cancer	0.00338	0.0151	CbGeAlD
Trandolapril—SLC15A2—lymph node—urinary bladder cancer	0.00295	0.0131	CbGeAlD
Trandolapril—Nateglinide—PPARG—urinary bladder cancer	0.00175	0.0674	CrCbGaD
Trandolapril—Drowsiness—Doxorubicin—urinary bladder cancer	0.000544	0.000725	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—urinary bladder cancer	0.000544	0.000725	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000539	0.000719	CcSEcCtD
Trandolapril—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000538	0.000717	CcSEcCtD
Trandolapril—Bradycardia—Epirubicin—urinary bladder cancer	0.000537	0.000717	CcSEcCtD
Trandolapril—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000536	0.000715	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—urinary bladder cancer	0.000535	0.000713	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000533	0.000711	CcSEcCtD
Trandolapril—Urticaria—Etoposide—urinary bladder cancer	0.000532	0.000709	CcSEcCtD
Trandolapril—Rhinitis—Epirubicin—urinary bladder cancer	0.000529	0.000706	CcSEcCtD
Trandolapril—Body temperature increased—Etoposide—urinary bladder cancer	0.000529	0.000705	CcSEcCtD
Trandolapril—Abdominal pain—Etoposide—urinary bladder cancer	0.000529	0.000705	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000529	0.000705	CcSEcCtD
Trandolapril—Hepatitis—Epirubicin—urinary bladder cancer	0.000528	0.000704	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—urinary bladder cancer	0.000527	0.000703	CcSEcCtD
Trandolapril—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000527	0.000703	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—urinary bladder cancer	0.000526	0.000701	CcSEcCtD
Trandolapril—Asthenia—Cisplatin—urinary bladder cancer	0.000524	0.000699	CcSEcCtD
Trandolapril—Pharyngitis—Epirubicin—urinary bladder cancer	0.000524	0.000699	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000524	0.000698	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—urinary bladder cancer	0.000522	0.000696	CcSEcCtD
Trandolapril—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000521	0.000695	CcSEcCtD
Trandolapril—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00052	0.000693	CcSEcCtD
Trandolapril—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000519	0.000692	CcSEcCtD
Trandolapril—Urethral disorder—Epirubicin—urinary bladder cancer	0.000517	0.00069	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000515	0.000686	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—urinary bladder cancer	0.000513	0.000684	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—urinary bladder cancer	0.000512	0.000682	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—urinary bladder cancer	0.000509	0.000679	CcSEcCtD
Trandolapril—Dizziness—Fluorouracil—urinary bladder cancer	0.000509	0.000679	CcSEcCtD
Trandolapril—Visual impairment—Epirubicin—urinary bladder cancer	0.000509	0.000678	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000508	0.000678	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000508	0.000677	CcSEcCtD
Trandolapril—Diarrhoea—Cisplatin—urinary bladder cancer	0.0005	0.000666	CcSEcCtD
Trandolapril—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000499	0.000666	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—urinary bladder cancer	0.000498	0.000665	CcSEcCtD
Trandolapril—Vomiting—Gemcitabine—urinary bladder cancer	0.000498	0.000664	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—urinary bladder cancer	0.000497	0.000663	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—urinary bladder cancer	0.000494	0.000659	CcSEcCtD
Trandolapril—Rash—Gemcitabine—urinary bladder cancer	0.000494	0.000659	CcSEcCtD
Trandolapril—Dermatitis—Gemcitabine—urinary bladder cancer	0.000494	0.000658	CcSEcCtD
Trandolapril—Eye disorder—Epirubicin—urinary bladder cancer	0.000493	0.000658	CcSEcCtD
Trandolapril—Hypersensitivity—Etoposide—urinary bladder cancer	0.000493	0.000657	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—urinary bladder cancer	0.000492	0.000656	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—urinary bladder cancer	0.000491	0.000655	CcSEcCtD
Trandolapril—Headache—Gemcitabine—urinary bladder cancer	0.000491	0.000654	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00049	0.000653	CcSEcCtD
Trandolapril—Flushing—Epirubicin—urinary bladder cancer	0.00049	0.000653	CcSEcCtD
Trandolapril—Vomiting—Fluorouracil—urinary bladder cancer	0.00049	0.000653	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—urinary bladder cancer	0.00049	0.000653	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—urinary bladder cancer	0.000488	0.000651	CcSEcCtD
Trandolapril—Rash—Fluorouracil—urinary bladder cancer	0.000486	0.000648	CcSEcCtD
Trandolapril—Dermatitis—Fluorouracil—urinary bladder cancer	0.000485	0.000647	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000485	0.000646	CcSEcCtD
Trandolapril—Headache—Fluorouracil—urinary bladder cancer	0.000483	0.000644	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000482	0.000643	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000481	0.000642	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—urinary bladder cancer	0.000481	0.000641	CcSEcCtD
Trandolapril—Asthenia—Etoposide—urinary bladder cancer	0.00048	0.00064	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00048	0.00064	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—urinary bladder cancer	0.000479	0.000639	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000479	0.000638	CcSEcCtD
Trandolapril—Immune system disorder—Epirubicin—urinary bladder cancer	0.000477	0.000636	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000476	0.000634	CcSEcCtD
Trandolapril—Back pain—Methotrexate—urinary bladder cancer	0.000475	0.000633	CcSEcCtD
Trandolapril—Pruritus—Etoposide—urinary bladder cancer	0.000473	0.000631	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—urinary bladder cancer	0.000472	0.000629	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—urinary bladder cancer	0.000471	0.000628	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—urinary bladder cancer	0.000466	0.000622	CcSEcCtD
Trandolapril—Nausea—Gemcitabine—urinary bladder cancer	0.000465	0.000621	CcSEcCtD
Trandolapril—Vomiting—Cisplatin—urinary bladder cancer	0.000464	0.000619	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—urinary bladder cancer	0.000462	0.000617	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000462	0.000616	CcSEcCtD
Trandolapril—Rash—Cisplatin—urinary bladder cancer	0.00046	0.000614	CcSEcCtD
Trandolapril—Dermatitis—Cisplatin—urinary bladder cancer	0.00046	0.000613	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—urinary bladder cancer	0.00046	0.000613	CcSEcCtD
Trandolapril—Diarrhoea—Etoposide—urinary bladder cancer	0.000458	0.00061	CcSEcCtD
Trandolapril—Nausea—Fluorouracil—urinary bladder cancer	0.000458	0.00061	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—urinary bladder cancer	0.000456	0.000609	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000456	0.000607	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—urinary bladder cancer	0.000455	0.000607	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—urinary bladder cancer	0.000454	0.000605	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—urinary bladder cancer	0.000453	0.000604	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000453	0.000604	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—urinary bladder cancer	0.000453	0.000604	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—urinary bladder cancer	0.00045	0.0006	CcSEcCtD
Trandolapril—Back pain—Epirubicin—urinary bladder cancer	0.000444	0.000593	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—urinary bladder cancer	0.000443	0.000591	CcSEcCtD
Trandolapril—Malaise—Methotrexate—urinary bladder cancer	0.000443	0.00059	CcSEcCtD
Trandolapril—Dizziness—Etoposide—urinary bladder cancer	0.000442	0.00059	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—urinary bladder cancer	0.000442	0.000589	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000441	0.000588	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—urinary bladder cancer	0.000441	0.000588	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00044	0.000587	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—urinary bladder cancer	0.00044	0.000586	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000436	0.000582	CcSEcCtD
Trandolapril—Nausea—Cisplatin—urinary bladder cancer	0.000434	0.000578	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—urinary bladder cancer	0.000432	0.000576	CcSEcCtD
Trandolapril—Cough—Methotrexate—urinary bladder cancer	0.000428	0.000571	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—urinary bladder cancer	0.000428	0.000571	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000426	0.000569	CcSEcCtD
Trandolapril—Vomiting—Etoposide—urinary bladder cancer	0.000425	0.000567	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—urinary bladder cancer	0.000425	0.000567	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—urinary bladder cancer	0.000425	0.000566	CcSEcCtD
Trandolapril—Agitation—Epirubicin—urinary bladder cancer	0.000422	0.000563	CcSEcCtD
Trandolapril—Rash—Etoposide—urinary bladder cancer	0.000422	0.000562	CcSEcCtD
Trandolapril—Dermatitis—Etoposide—urinary bladder cancer	0.000421	0.000562	CcSEcCtD
Trandolapril—Headache—Etoposide—urinary bladder cancer	0.000419	0.000559	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—urinary bladder cancer	0.000419	0.000559	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—urinary bladder cancer	0.000418	0.000557	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—urinary bladder cancer	0.000418	0.000557	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—urinary bladder cancer	0.000418	0.000557	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000416	0.000555	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000415	0.000554	CcSEcCtD
Trandolapril—Malaise—Epirubicin—urinary bladder cancer	0.000414	0.000553	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—urinary bladder cancer	0.000413	0.000551	CcSEcCtD
Trandolapril—Vertigo—Epirubicin—urinary bladder cancer	0.000413	0.00055	CcSEcCtD
Trandolapril—Syncope—Epirubicin—urinary bladder cancer	0.000412	0.000549	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—urinary bladder cancer	0.000411	0.000548	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—urinary bladder cancer	0.000411	0.000548	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000409	0.000545	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—urinary bladder cancer	0.000406	0.000541	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000404	0.000539	CcSEcCtD
Trandolapril—Cough—Epirubicin—urinary bladder cancer	0.000401	0.000535	CcSEcCtD
Trandolapril—Infection—Methotrexate—urinary bladder cancer	0.000398	0.000531	CcSEcCtD
Trandolapril—Nausea—Etoposide—urinary bladder cancer	0.000397	0.00053	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000395	0.000526	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000393	0.000524	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—urinary bladder cancer	0.000393	0.000524	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000392	0.000523	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—urinary bladder cancer	0.000391	0.000522	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—urinary bladder cancer	0.000391	0.000522	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—urinary bladder cancer	0.000391	0.000522	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—urinary bladder cancer	0.000391	0.000521	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—urinary bladder cancer	0.00039	0.00052	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—urinary bladder cancer	0.000389	0.000519	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000389	0.000518	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000387	0.000517	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—urinary bladder cancer	0.000387	0.000515	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—urinary bladder cancer	0.000383	0.000511	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—urinary bladder cancer	0.000383	0.00051	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—urinary bladder cancer	0.000382	0.000509	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—urinary bladder cancer	0.000382	0.000509	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—urinary bladder cancer	0.000381	0.000508	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—urinary bladder cancer	0.000381	0.000507	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—urinary bladder cancer	0.000376	0.000501	CcSEcCtD
Trandolapril—Oedema—Epirubicin—urinary bladder cancer	0.000375	0.0005	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—urinary bladder cancer	0.000374	0.000499	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000374	0.000498	CcSEcCtD
Trandolapril—Infection—Epirubicin—urinary bladder cancer	0.000373	0.000497	CcSEcCtD
Trandolapril—Cough—Doxorubicin—urinary bladder cancer	0.000371	0.000495	CcSEcCtD
Trandolapril—Shock—Epirubicin—urinary bladder cancer	0.000369	0.000492	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000368	0.00049	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000367	0.00049	CcSEcCtD
Trandolapril—Tachycardia—Epirubicin—urinary bladder cancer	0.000366	0.000488	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000365	0.000487	CcSEcCtD
Trandolapril—Skin disorder—Epirubicin—urinary bladder cancer	0.000364	0.000486	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000363	0.000483	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—urinary bladder cancer	0.000362	0.000483	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—urinary bladder cancer	0.000362	0.000483	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—urinary bladder cancer	0.000362	0.000483	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—urinary bladder cancer	0.000362	0.000483	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—urinary bladder cancer	0.000361	0.000481	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—urinary bladder cancer	0.00036	0.00048	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000359	0.000479	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—urinary bladder cancer	0.000358	0.000477	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—urinary bladder cancer	0.000357	0.000477	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—urinary bladder cancer	0.000357	0.000476	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—urinary bladder cancer	0.000356	0.000475	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—urinary bladder cancer	0.000354	0.000472	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—urinary bladder cancer	0.000353	0.00047	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—urinary bladder cancer	0.00035	0.000467	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—urinary bladder cancer	0.000348	0.000465	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—urinary bladder cancer	0.000347	0.000463	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000346	0.000461	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—urinary bladder cancer	0.000346	0.000461	CcSEcCtD
Trandolapril—Infection—Doxorubicin—urinary bladder cancer	0.000345	0.00046	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000342	0.000456	CcSEcCtD
Trandolapril—Shock—Doxorubicin—urinary bladder cancer	0.000341	0.000455	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00034	0.000454	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00034	0.000453	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—urinary bladder cancer	0.000339	0.000452	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—urinary bladder cancer	0.000339	0.000452	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—urinary bladder cancer	0.000337	0.000449	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—urinary bladder cancer	0.000337	0.000449	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000335	0.000447	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—urinary bladder cancer	0.000334	0.000446	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—urinary bladder cancer	0.000333	0.000445	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—urinary bladder cancer	0.000331	0.000441	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00033	0.00044	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—urinary bladder cancer	0.00033	0.00044	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000328	0.000437	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—urinary bladder cancer	0.000326	0.000435	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—urinary bladder cancer	0.000324	0.000432	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000324	0.000432	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—urinary bladder cancer	0.000323	0.000431	CcSEcCtD
Trandolapril—Constipation—Epirubicin—urinary bladder cancer	0.000321	0.000428	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—urinary bladder cancer	0.000318	0.000425	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—urinary bladder cancer	0.000317	0.000422	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—urinary bladder cancer	0.000317	0.000422	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000316	0.000422	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—urinary bladder cancer	0.000314	0.000418	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000312	0.000415	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000309	0.000413	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000309	0.000412	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—urinary bladder cancer	0.000308	0.000411	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000307	0.000409	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000305	0.000407	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000302	0.000402	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.0003	0.000399	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—urinary bladder cancer	0.000299	0.000399	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—urinary bladder cancer	0.000298	0.000397	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—urinary bladder cancer	0.000297	0.000396	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—urinary bladder cancer	0.000296	0.000395	CcSEcCtD
Trandolapril—Body temperature increased—Epirubicin—urinary bladder cancer	0.000296	0.000395	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000295	0.000394	CcSEcCtD
Trandolapril—Asthenia—Methotrexate—urinary bladder cancer	0.000288	0.000383	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000286	0.000381	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000284	0.000378	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—urinary bladder cancer	0.000284	0.000378	CcSEcCtD
Trandolapril—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000276	0.000368	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—urinary bladder cancer	0.000276	0.000368	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000274	0.000366	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000274	0.000366	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—urinary bladder cancer	0.000274	0.000366	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—urinary bladder cancer	0.000269	0.000359	CcSEcCtD
Trandolapril—Pruritus—Epirubicin—urinary bladder cancer	0.000265	0.000354	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—urinary bladder cancer	0.000265	0.000353	CcSEcCtD
Trandolapril—Diarrhoea—Epirubicin—urinary bladder cancer	0.000257	0.000342	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000256	0.000341	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—urinary bladder cancer	0.000255	0.00034	CcSEcCtD
Trandolapril—Rash—Methotrexate—urinary bladder cancer	0.000253	0.000337	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—urinary bladder cancer	0.000252	0.000337	CcSEcCtD
Trandolapril—Headache—Methotrexate—urinary bladder cancer	0.000251	0.000335	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—urinary bladder cancer	0.000249	0.000332	CcSEcCtD
Trandolapril—Dizziness—Epirubicin—urinary bladder cancer	0.000248	0.000331	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—urinary bladder cancer	0.000246	0.000327	CcSEcCtD
Trandolapril—Vomiting—Epirubicin—urinary bladder cancer	0.000238	0.000318	CcSEcCtD
Trandolapril—Nausea—Methotrexate—urinary bladder cancer	0.000238	0.000317	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000237	0.000317	CcSEcCtD
Trandolapril—Rash—Epirubicin—urinary bladder cancer	0.000236	0.000315	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—urinary bladder cancer	0.000236	0.000315	CcSEcCtD
Trandolapril—Headache—Epirubicin—urinary bladder cancer	0.000235	0.000313	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—urinary bladder cancer	0.000229	0.000306	CcSEcCtD
Trandolapril—Nausea—Epirubicin—urinary bladder cancer	0.000223	0.000297	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—urinary bladder cancer	0.000221	0.000294	CcSEcCtD
Trandolapril—Rash—Doxorubicin—urinary bladder cancer	0.000219	0.000292	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—urinary bladder cancer	0.000219	0.000291	CcSEcCtD
Trandolapril—Headache—Doxorubicin—urinary bladder cancer	0.000217	0.00029	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—urinary bladder cancer	0.000206	0.000275	CcSEcCtD
